Neurotrope (NASDAQ:NTRP)

Neurotrope (NASDAQ:NTRP)


Share Price
$ 6.48
Change
0.33 (5.37 %)
Market Cap
$83.90 m
Proactive Investors - Run By Investors For Investors

Neurotrope

Neurotrope operates as a clinical-stage biopharmaceutical and diagnostics company. Its two product platforms include a minimally-invasive diagnostic test for Alzheimer's disease and a drug candidate, known as bryostatin for the treatment of Alzheimer's disease, both of which are in the clinical testing stage.

EPIC: NTRP
Market: NASDAQ:NTRP
52-week High/Low: $11.90 / $3.34
Sector: Pharma & Biotech
Market Cap: $83.90 m
Website: www.neurotropebioscience.com
col 3
col 4
col 5
col 6

Neurotrope Timeline

Market Reports Including NTRP

VIEW ALL
Video RSS

Videos

VIEW ALL VIDEOS
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use